Skip to content
★ Sign in to follow
PN

Peter Nordkild

Asarina Pharma AB
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€216k
▼ Sales (0 ops.)
—

Latest filing published 21 Sept 2018 for Asarina Pharma AB, €135k.

Filing timeline

BuySale
Peter Nordkild

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Peter Nordkild: trading record in brief

Peter Nordkild discloses dealings in Asarina Pharma AB to Finansinspektionen. We count 2 filings, every one of them for a trade on 18 September 2018.

The open-market record is one-sided, with 2 purchases worth €216k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The newest entry dates from 21 September 2018: an open-market purchase of €135k, in Asarina Pharma AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Peter Nordkild

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    CEOExecutivesAsarina Pharma AB
    1M SEK48FI-SE
    67,000 shares@ SEK 21.00100.0% of flowAktieISIN SE0011641794FI:csv-7dffaa8d1beaed74756d
    Canonical exit: 17 Dec 2018 (T+90)
  • ▲
    CEOExecutivesAsarina Pharma AB
    840,000 SEK30FI-SE
    40,000 shares@ SEK 21.00100.0% of flowAktieISIN SE0011641794FI:csv-ff41a4a393864ca4b7e3
    Canonical exit: 17 Dec 2018 (T+90)

2 of 2 declarations